Patents
Literature
Patsnap Eureka AI that helps you search prior art, draft patents, and assess FTO risks, powered by patent and scientific literature data.

6 results about "Calcium deficiencies" patented technology

Ingredient detection method of injection for preventing or treating vitamin or calcium deficiency of dairy cow

The invention belongs to the technical field of gas chromatography detection, and relates to a gas chromatography method for simultaneously determining the content of ethanol and isopropyl myristate. The set conditions of the gas chromatography are as follows: the temperature of an FID detector and a polyethylene glycol 20M capillary column is 240-260 DEG C, the temperature of the detector is 240-260 DEG C, the carrier gas is nitrogen, the flow rate is 0.9-2.5 mL / min, the sample injection amount is 1 mu L, the column temperature is increased by adopting a program, the initial temperature is 80-90 DEG C, the temperature is increased to 180-190 DEG C at the rate of 9-12 DEG C / min, and the temperature is maintained for at least 10 minutes. The method provided by the invention can realize simultaneous detection of ethanol and isopropyl myristate, after the two substances are dissolved by the N, N-dimethylformamide solvent, the detected spectrogram does not have the phenomena of peak overlapping, trailing and the like, and the method has the advantages of high separation efficiency, high selectivity, high sensitivity, high analysis speed and wide application range.
Owner:JINANSHENLANDONGWUBAOJIANPIN CO LTD

Compositions and methods using a combination of oleuropein and taurine

Composition comprising a combination of oleuropein or metabolite thereof and taurine or functional derivative thereof are provided. The composition may be an oral nutritional composition, for example a nutritional supplement, an oral nutritional supplement, a food product, a food for special medical purpose (FSMP). The composition can be administered to an individual in need thereof for improving a physiological state linked to metabolic fatigue in one or more cells, (ii) increasing mitochondrial energy and mitochondrial calcium uptake in one or more cells, and (iii) increasing antioxidant capacity, reducing oxidative stress and / or enhancing mitochondrial function, (iv) treating or preventing a calcium deficiency / depletion disorder in an individual. Additionally or alternatively, the method can treat or prevent a mitochondria-related disease or a condition associated with altered mitochondrial function in an individual in need thereof or at risk thereof.
Owner:SOCIETE DES PRODUITS NESTLE SA

Calcium-Enhanced Plants And Methods Therefor

PendingUS20260150844A1BiocidePlant growth regulatorsGrowth stimulantActive agent
Disclosed herein are micro-sized aragonite compositions and methods for enhancing calcium uptake and overall plant health. The disclosure provides calcium compositions comprising particles of aragonite, preferably oolitic aragonite, that are mechanically reduced to micron or sub-micron dimensions to generate a highly bioavailable, rapidly dissolving calcium source suitable for foliar or soil application. The compositions may be incorporated into liquid suspensions, granules, coated fertilizers, seed treatments, or nutrient delivery systems, and may optionally include biologically active agents, growth stimulants, humates, or surfactants to further promote uptake. Methods of using the compositions to treat calcium deficiency, strengthen cell walls, reduce blossom-end rot, increase stress tolerance, and improve yield are also provided.
Owner:NANT HOLDINGS IP LLC

Composition for the prophylaxis and treatment of calcium deficiency and osteoporosis

The invention relates to the pharmaceutical industry and can be used for creating a medicinal preparation or dietary supplement for the prophylaxis and treatment of calcium deficiency and osteoporosis. The essence of the invention consists in a composition for the prophylaxis and treatment of calcium deficiency and osteoporosis which contains tribasic calcium phosphate, magnesium hydroxide, cholecalciferol, pyridoxine hydrochloride, resveratrol, astragaloside IV, sodium selenate, zinc oxide and sodium borate. The technical result of the invention lies in more effective prophylaxis and treatment of calcium deficiency and osteoporosis, together with increased calcium absorption into bone tissue, as well as in a tailored medical effect which consists in preventing loss of bone mass in postmenopausal women with no obvious symptoms of osteoporosis.
Owner:BAZHUTIN ALEKSANDR DMITRIEVICH

Compositions and methods using a combination of oleuropein and taurine

A composition is provided that includes a combination of oleuropein or a metabolite thereof and taurine or a functional derivative thereof. The composition may be an oral nutritional composition, such as a dietary supplement, an oral nutritional supplement, a food product, or a food for special medical purposes (FSMP). The composition can be administered to an individual in need thereof for (ii) improving a physiological condition associated with metabolic fatigue in one or more cells, (iii) increasing mitochondrial energy and mitochondrial calcium uptake in one or more cells, and (iv) improving antioxidant capacity, reducing oxidative stress, and / or enhancing mitochondrial function, or (iv) treating or preventing calcium deficiency / depletion disorders in the individual. Additionally or alternatively, the method can be used to treat or prevent a mitochondrial-related disease or condition associated with altered mitochondrial function in an individual in need of or at risk for such disease or condition.
Owner:SOCIETE DES PRODUITS NESTLE SA

Medicinal synanthrin chelated calcium preparation, preparation thereof and application of medicinal synanthrin chelated calcium preparation in calcium deficiency diseases

The invention belongs to the technical field of calcium supplement preparations, and particularly relates to a medicinal synanthrin chelated calcium preparation and preparation and application thereof in calcium deficiency diseases, the medicinal synanthrin chelated calcium preparation comprises synanthrin chelated calcium and microcapsules coating the synanthrin chelated calcium, and wall materials of the microcapsules comprise maltodextrin and gelatin; the synanthrin chelated calcium has carboxymethyl synanthrin macromolecules and calcium ions chelated with the macromolecules, carboxyl groups in the carboxymethyl synanthrin macromolecules are combined with the calcium ions through coordinate bonds, the molar ratio of the synanthrin macromolecules to the calcium ions is 1: (0.1-1.4), and the substitution degree of carboxymethyl is 0.20-2.80. The purity of the preparation is larger than or equal to 95%, the highest purity can reach 99.2%, the preparation can reach the medicinal level, the product stability is good, targeted absorption is promoted, the absorption rate is high, the preparation is suitable for efficient calcium supplement, and the preparation has the advantages of being high in absorption rate, small in gastrointestinal tract stimulation, having the prebiotics function and the like and is especially suitable for osteoporosis, rickets, climacteric syndromes and other calcium deficiency related diseases.
Owner:JUNLIN PHARMACEUTICAL TECHNOLOGY (NINGBO) CO LTD